Medication

1010 WINS Newsroom
July 07, 2020 - 9:00 am
A Brazilian man infected with the AIDS virus has shown no sign of it for more than a year since he stopped HIV medicines after an intense experimental drug therapy aimed at purging hidden, dormant virus from his body, doctors reported Tuesday. The case needs independent verification and it’s way...
Read More
FILE - In this Dec. 1, 2018, file photo, Indians participate in a health awareness run to mark World AIDS Day in Hyderabad, India. New numbers on the global AIDS epidemic show some big successes such as fewer deaths and new infections. But there are also some tragic failures: Only half of children with HIV, the virus that causes the disease, are getting treatment. UNAIDS, a United Nations agency, reported last year's numbers Monday, July 6, 2020, at the start of an international AIDS conference. (AP Photo/Mahesh Kumar A., File)
1010 WINS Newsroom
July 06, 2020 - 10:41 am
New numbers on the global AIDS epidemic show some big successes, such as fewer deaths and new infections. But there are also some tragic failures: Only half the children with HIV, the virus that causes the disease, are getting treatment. “We are making great progress against the HIV epidemic .....
Read More
In this June 5, 2020 photo provided by the Mountain Area Health Education Center, physicians, residents and staff from the facility in Asheville, N.C., take a knee to show support for renewed calls for racial justice after the police killing of George Floyd. Government statistics from late January through May 30 suggest an increase in U.S. deaths from chronic diseases compared with historical trends. They include 7,000 excess deaths from hypertension, about 4,000 from diabetes and 3,000 from strokes -- all conditions that disproportionately affect Blacks, although the data don’t include race. (Brenda Benik/MAHEC via AP)
1010 WINS Newsroom
July 05, 2020 - 10:07 am
Doctors have known it for a long time, well before the resounding cries of “Black Lives Matter”: Black people suffer disproportionately. They face countless challenges to good health, among them food, transportation and income. The stress of living with racism has very real, physical effects. And...
Read More
Sex workers wait for clients in the red light district of Harare, Zimbabwe, Friday, June 12, 2020. As the coronavirus spreads in Africa, it increasingly threatens those who earn their living on the streets, including sex workers with HIV. (AP Photo/Tsvangirayi Mukwazhi)
1010 WINS Newsroom
July 04, 2020 - 4:02 am
KIGALI, Rwanda (AP) — As the coronavirus spreads in Africa, it threatens in multiple ways those who earn their living on the streets — people like Mignonne, a 25-year-old sex worker with HIV. The lockdown in Rwanda has kept many of her customers away, she said, so she has less money to buy food...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
1010 WINS Newsroom
July 01, 2020 - 3:33 pm
LONDON (AP) — Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19. The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
1010 WINS Newsroom
June 29, 2020 - 11:54 am
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for...
Read More
FILE - In this Jan. 27, 2018 file photo, Honduran President Juan Orlando Hernandez, left, stands with his wife Ana Garcia, during the presidential inauguration ceremony for his second term at the National Stadium in Tegucigalpa, Honduras. Hernández and his wife have tested positive for COVID-19, the Central American leader said late Tuesday, June 16, 2020, in a television message. (AP Photo/Fernando Antonio, File)
1010 WINS Newsroom
June 17, 2020 - 3:07 pm
TEGUCIGALPA, Honduras (AP) — Honduran President Juan Orlando Hernández was hospitalized Wednesday with pneumonia, hours after announcing that he and his wife had tested positive for COVID-19. Francis Contreras, spokesman for the National System of Risk Management, said in a news conference that...
Read More
Dexamethasone
Matthew Horwood/Getty Images
1010 WINS Newsroom
June 16, 2020 - 10:31 pm
ATLANTA (AP) — As nations grapple with new outbreaks and spiking death tolls from the coronavirus, a commonly available drug appeared Tuesday to offer hope that the most seriously ill could have a better chance of survival. The pandemic has forced countries to impose lockdowns and tough...
Read More
FILE - In this April 9, 2020 file photo, a chemist displays hydroxychloroquine tablets in New Delhi, India. U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19. The Food and Drug Administration said Monday, June 15 that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. (AP Photo/Manish Swarup, File)
1010 WINS Newsroom
June 15, 2020 - 5:27 pm
WASHINGTON (AP) — U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause serious side effects. The Food and Drug Administration said the drugs hydroxychloroquine and...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Friday, June 5, 2020, leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. (AP Photo/John Locher)
1010 WINS Newsroom
June 05, 2020 - 12:34 pm
Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. Results released Friday from 1,542 patients showed...
Read More

Pages